Journal of Cardiovascular Pharmacology, 1533-4023

Journal

More filtering options
More filtering options

All authors

Reset
to
1 - 15 out of 15Page size: 25
Sort by: Title

  1. Upregulation of a non-ETA receptor in human arteries in vitro

    Mikael Adner, David Erlinge, Lars Nilsson & Leif Edvinsson, 1995, In: Journal of Cardiovascular Pharmacology. 26, Suppl. 3, p. 314-316

    Research output: Contribution to journal › Article

  2. Triptans Induce Vasoconstriction of Human Arteries and Veins from the Thoracic Wall.

    Angelica Wackenfors, Malin Jarvius, Richard Ingemansson, Lars Edvinsson & Malin Malmsjö, 2005, In: Journal of Cardiovascular Pharmacology. 45, 5, p. 476-484

    Research output: Contribution to journal › Article

  3. P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells.

    Lingwei Wang, Lena Karlsson, Sara Moses, Anna Hultgårdh-Nilsson, Maria Andersson, Catharina Cedercrantz-Borna, Tomas Gudbjartsson, Sverker Jern & David Erlinge, 2002, In: Journal of Cardiovascular Pharmacology. 40, 6, p. 841-853

    Research output: Contribution to journal › Article

  5. Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study

    Andreas Jekell, Karin Malmqvist, N Håkan Wallén, David Mörtsell & Thomas Kahan, 2013 Dec, In: Journal of Cardiovascular Pharmacology. 62, 6, p. 559-66

    Research output: Contribution to journal › Article

  6. Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.

    Annaeva Wiklund, David Kylhammar & Göran Rådegran, 2012, In: Journal of Cardiovascular Pharmacology. 59, 5, p. 441-449

    Research output: Contribution to journal › Article

  7. Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries

    Anton Holmgren, Emil Pantev, David Erlinge & Lars Edvinsson, 1998, In: Journal of Cardiovascular Pharmacology. 32, 4, p. 662-664

    Research output: Contribution to journal › Article

  8. Exploration of Physiological and Pathophysiological Implications of miRNA-143 and miRNA-145 in Cerebral Arteries

    Simon Topp Christensen, Sara Ellinor Johansson, Karin Warfvinge, Thomas Braun, Thomas Boettger, Lars Edvinsson & Kristian Agmund Haanes, 2019, In: Journal of Cardiovascular Pharmacology. 74, 5, p. 409-419 11 p.

    Research output: Contribution to journal › Article

  9. Effects of the combined ETA and ETB receptor antagonist PD145065 on arteries, arterioles, and veins in the cat hindlimb

    Ulf Ekelund, Mikael Adner, Lars Edvinsson & Stefan Mellander, 1995, In: Journal of Cardiovascular Pharmacology. 26, Suppl. 3, p. 211-213

    Research output: Contribution to journal › Article

  10. Effects of carvedilol on the metabolic, hemodynamic, and electrocardiographic responses to increased plasma epinephrine in normal subjects

    Ole Hansen, B W Johansson, Peter Nilsson-Ehle, B Eklund, I Ohlsson, E Palenmark, Ann-Mari Pauler & K Svensson, 1994, In: Journal of Cardiovascular Pharmacology. 24, 6, p. 853-859

    Research output: Contribution to journal › Article

  14. Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors

    Torun Nilsson, David Erlinge, Leonor Cantera & Lars Edvinsson, 1996, In: Journal of Cardiovascular Pharmacology. 28, 6, p. 764-768

    Research output: Contribution to journal › Article

  15. Comparison of the Vasoconstrictor Effects of the Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist Telcagepant (MK-0974) and Zolmitriptan in Human Isolated Coronary Arteries.

    Joseph J Lynch, Christopher P Regan, Lars Edvinsson, Richard J Hargreaves & Stefanie A Kane, 2010, In: Journal of Cardiovascular Pharmacology. 55, 5, p. 518-521

    Research output: Contribution to journal › Article